Field Trip Health to Expand to Psilocybin Treatment in the US Nov 6 • 2 min read Field Trip Health (CSE: FTRP) announced today that it is actively identifying potential locations to open Health Centers in Oregon to provide psilocybin therapies. This news is quickly following up on the passage of Measure 109 in Oregon on November 3, 2020 allowing the Oregon Health Authority to license and regulate a program for the…
Mydecine Innovations Group Retains KCSA Strategic Communications Nov 6 • 4 min read Mydecine Innovations Group announced that it has retained KCSA Strategic Communications as its agency of record.
Cybin Completes Reverse Take-Over Transaction Nov 5 • 10 min read CYBIN Inc. announced it has completed its previously announced reverse takeover of Clarmin Explorations Inc.
What Decriminalization in Oregon and DC Means for Psychedelic Investors Nov 5 • 3 min read November 3rd was a historic day for the psychedelic community as three major ballots were passed that will further the adoption of psychedelics. Measure 109 in Oregon: legalizes the use of psilocybin in therapy Measure 110 in Oregon: decriminalizes the possession of psilocybin (and other drugs) Initiative 81 in Washington DC: decriminalizes the possession of…
Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement Nov 5 • 5 min read Nova Mentis Life Science Corp. announced that its pending acquisition target, Pilz Bioscience Corp., has entered into a psilocybin manufacturing agreement with a pharmaceutical company with over 800 employees.